Yale University

Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population.

TitleModeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population.
Publication TypeJournal Article
Year of Publication2008
AuthorsBae, Seung Jin, David A. Paltiel, Anne L. Fuhlbrigge, Scott T. Weiss, and Karen M. Kuntz
JournalValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Volume11
Issue1
Pagination110-8
Date Published2008 Jan-Feb
ISSN1524-4733
KeywordsAdrenal Cortex Hormones, Adult, Age Factors, Anti-Asthmatic Agents, Asthma, Cost Sharing, Drug Prescriptions, Health Services Accessibility, Humans, Insurance, Pharmaceutical Services, Massachusetts, Medicaid, Models, Econometric, Nebulizers and Vaporizers, Outcome Assessment (Health Care), State Health Plans, Treatment Refusal, United States
AbstractThe Commonwealth of Massachusetts increased the copayment for prescription drugs by $1.50 for Medicaid (MassHealth) beneficiaries in 2003. We sought to determine the likely health outcomes and cost shifts attributable to this copayment increase using the example of inhaled corticosteroids (ICS) use among adult asthmatic Medicaid beneficiaries.
DOI10.1111/j.1524-4733.2010.00763.x
Alternate JournalValue Health

External Links